Id2 exacerbates the development of rheumatoid arthritis by increasing IFN‐γ production in CD4+ T cells

Id2 exacerbates the development of rheumatoid arthritis by increasing IFN‐γ production in CD4+ T cells

Abstract Purpose This research investigates the role of inhibitor of differentiation 2 (Id2) in the synthesis of pro‐inflammatory cytokines, specifically interferon‐γ (IFN‐γ) and interleukin‐17 (IL‐17), by various subsets of T cells, and its pathogenic role in rheumatoid arthritis (RA). Methods Flow...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haoyang Sun, Jinlin Miao, Kui Zhang, Peiyan Zhang, Haomiao Shen, Jiawei Wang, Bei Zhang, Junfeng Jia, Zhaohui Zheng, Ping Zhu
Format:	Article
Language:	English
Published:	Wiley 2025-03-01
Series:	Clinical and Translational Medicine
Subjects:	abatacept IFN‐γ inhibitor of differentiation 2 rheumatoid arthritis T cell
Online Access:	https://doi.org/10.1002/ctm2.70242
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of the pharmacokinetics of an experimental combined form of IFNα and IFNγ for intranasal use
by: E. V. Kravchenko, et al.
Published: (2024-09-01)

IFNγ production during cell interactions distinguishes localized from diffuse pigmented villonodular synovitis and rheumatoid arthritis
by: Mélissa Noack, et al.
Published: (2025-07-01)

IFN-γ-INDUCED PROTEIN 10 (IP-10) IN RHEUMATOID ARTHRITIS: LITERATURE REVIEW AND THE AUTHORS' OWN DATA
by: A. S. Avdeeva
Published: (2018-01-01)

Development of an ELISPOT assay for numerating IFN-γ-secreting T cells in chicken using novel monoclonal antibodies
by: Zhou Zhou, et al.
Published: (2025-10-01)

Optimizing Microneutralization and IFN-γ ELISPOT Assays to Evaluate Mpox Immunity
by: Yinyi Yu, et al.
Published: (2024-12-01)

Experience with abatacept used in the treatment of patients with rheumatoid arthritis
by: V I Mazurov, et al.
Published: (2011-12-01)

Abatacept and cardiovascular risk in rheumatoid arthritis: update
by: T. V. Popkova
Published: (2018-01-01)

IFNγ-INDUCED KINURENINE PRODUCTION AND INDOLAMINE 2,3-DIOXYGENASE GENE EXPRESSION IN PSORIASIS
by: D. A. Kaut, et al.
Published: (2014-07-01)

Effect of linex treatment on IFN-γ and IL-4 in mice infected with Trichinella
by: Shimaa Attia Atta, et al.
Published: (2024-11-01)

Administration of a Recombinant Fusion Protein of IFN-γ and CD154 Inhibited the Infection of Chicks with <i>Salmonella enterica</i>
by: Jingya Zhang, et al.
Published: (2025-02-01)

Development of a Monoclonal Antibody Against Duck IFN-γ Protein and the Application for Intracellular Cytokine Staining
by: Yingyi Chen, et al.
Published: (2025-03-01)

Investigation the level of IL-10 and IFN-γ in mice infected with Entamoeba histolytica and treated with earthworm powder
by: Nebrass Faleh Chachain, et al.
Published: (2019-08-01)

The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis
by: Alberto Floris, et al.
Published: (2025-01-01)

Periostin and IFN-γ levels in serum and nasopharyngeal aspirate in infants with viral-induced wheezing - 2 year follow-up
by: Sirma Mileva, et al.
Published: (2022-12-01)

A lymphostatin homologue from Chlamydia pecorum inhibits mitogen-activated bovine T cell proliferation and IFNγ production
by: Elizabeth A. Blackburn, et al.
Published: (2025-12-01)

The Influence of Nigella sativa on the Increase of IFN-γ and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy
by: Reza Aditya Mahendra, et al.
Published: (2025-01-01)

Change of autoantibody levels in established rheumatoid arthritis patients treated by biological disease-modifying anti-rheumatic drugs -the AIRTIGHT study-
by: Shohei Anno, et al.
Published: (2025-07-01)

Safety and efficacy of abatacept among patients with refractory rheumatoid arthritis: Experience from a North Indian Tertiary Care Hospital
by: M N Arjun, et al.
Published: (2018-01-01)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF ABATACEPT IN PATIENTS WITH DIFFERENT DURATION OF RHEUMATOID ARTHRITIS
by: M. A. Borisova, et al.
Published: (2017-01-01)

Inhibition of the Na+-glucose transporter SGLT2 reduces glucose uptake and IFNγ release from activated human CD4+ T cells
by: Zhe Jin, et al.
Published: (2025-06-01)

Regulation of Colonic Inflammation and Macrophage Homeostasis of IFN-γ-Primed Canine AMSCs in Experimental Colitis in Mice
by: Chan-Hee Jo, et al.
Published: (2024-11-01)

The inhibitory receptor LAG3 affects NK cell IFN-γ production through glycolysis and the PSAT1/STAT1/IFNG pathway
by: Hongchi Ge, et al.
Published: (2025-06-01)

ECM1 expression in chronic liver disease: Regulation by EGF/STAT1 and IFNγ/NRF2 signalling
by: Yujia Li, et al.
Published: (2025-08-01)

Study on the efficacy of IFN-γ- and sPD-1-overexpressing BMSCs in enhancing immune effects for the treatment of lung adenocarcinoma
by: Yahui Xie, et al.
Published: (2025-03-01)

Systemic IL-10 and IFN-γ Levels in Respiratory Syncytial Virus- and Rhinovirus-Infected Bulgarian Children with Acute Bronchiolitis and Their Impact on Clinical Manifestation
by: Emiliya Kostadinova, et al.
Published: (2025-04-01)

Network pharmacology and UHPLC-HRMS reveal the mechanism of QSFZYL and BMSCs overexpressing IFN-γ against lung adenocarcinoma
by: Zhen Lv, et al.
Published: (2025-06-01)

IFN-γ gene polymorphisms +874 T/A and +2109 A/G are associated with the serofast state after early syphilis treatment: a prospective observational study
by: Konrad Kaminiów, et al.
Published: (2025-06-01)

Development of an interferon-γ release assay (IGRA) for detection of Brucella abortus and clinical diagnosis of brucellosis
by: Yu Feng, et al.
Published: (2017-12-01)

Efficacy and safety of abatacept in rheumatoid arthritis patients in Western region in Saudi Arabia: a multi-center study
by: Lina S. Alahmadi, et al.
Published: (2025-08-01)

ABATACEPT IN TREATMENT OF JUVENILE IDIOPATHIC ARTHRITIS: INTERNATIONAL DATA AND EXPERIENCE OF USAGE IN THE REPUBLIC OF MORDOVIA
by: L. A. Balykova, et al.
Published: (2014-03-01)

Investigating the Mechanism of IFN‐γ‐Inducible Lysosomal Thiol Reductase‐Mediated Inhibition of Breast Cancer Cell Proliferation
by: Qin Liu, et al.
Published: (2025-04-01)

Studying the Role of IFN-γ, Vitamin C, SOD, LH, FSH, APA and ACA in Toxoplasma gondii Infected Miscarriage Women
by: Ismael et al.
Published: (2019-09-01)

REGγ regulates antiviral response by activating TBK1-IFNβ signaling through degradation of PPP2CB
by: Yi Li, et al.
Published: (2025-07-01)

Anti-cyclic citrullinated peptide antibodies – a role in rheumatoid arthritis and the possibility of seroconversion: A focus on abatacept
by: N. V. Chichasova
Published: (2017-03-01)

Analysis of the clinical value and influencing factors of combined detection of tuberculosis-specific cytokines IFN-γ and IL-2 in the diagnosis of active tuberculosis in children and adolescents
by: Jinyu Chen, et al.
Published: (2025-08-01)

Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1
by: Shira Hagbi-Levi, et al.
Published: (2025-04-01)

Immunomodulatory effects of Eimeria maxima surface antigen (EmSAG) as an IFN-γ inhibitory molecule on peripheral blood mononuclear cells (PBMCs) and T cell subsets in chickens
by: Xianglin Pu, et al.
Published: (2025-05-01)

The prognostic and diagnostic significance of inflammatory markers TNF-α, IL-6, and IFN-γ in evaluating disease severity in diabetic foot infection
by: Shuo Wang, et al.
Published: (2025-07-01)

Balance of CD4<sup>+</sup>IFNγ+ and CD4<sup>+</sup>CD25<sup>hi</sup>T cells as early predictor of a 3-month outcome in ischemic stroke patients
by: S. A. Morozov, et al.
Published: (2020-08-01)

Curcumin inhibits IFN-γ induced PD-L1 expression via reduction of STAT1 Phosphorylation in A549 non-small cell lung cancer cells
by: Dian Jamel Salih, et al.
Published: (2025-06-01)